These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study. Arnold LM; Arsenault P; Huffman C; Patrick JL; Messig M; Chew ML; Sanin L; Scavone JM; Pauer L; Clair AG Curr Med Res Opin; 2014 Oct; 30(10):2069-83. PubMed ID: 24867298 [TBL] [Abstract][Full Text] [Related]
5. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113 [TBL] [Abstract][Full Text] [Related]
8. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial. van Seventer R; Bach FW; Toth CC; Serpell M; Temple J; Murphy TK; Nimour M Eur J Neurol; 2010 Aug; 17(8):1082-9. PubMed ID: 20236172 [TBL] [Abstract][Full Text] [Related]
9. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial. Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339 [TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial. Huffman CL; Goldenberg JN; Weintraub J; Sanin L; Driscoll J; Yang R; Chew ML; Scavone JM Clin J Pain; 2017 Jul; 33(7):569-578. PubMed ID: 27753650 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Arezzo JC; Rosenstock J; Lamoreaux L; Pauer L BMC Neurol; 2008 Sep; 8():33. PubMed ID: 18796160 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. Semel D; Murphy TK; Zlateva G; Cheung R; Emir B BMC Fam Pract; 2010 Nov; 11():85. PubMed ID: 21054853 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of pregabalin in patients with central post-stroke pain. Kim JS; Bashford G; Murphy KT; Martin A; Dror V; Cheung R Pain; 2011 May; 152(5):1018-1023. PubMed ID: 21316855 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy. Simpson DM; Rice AS; Emir B; Landen J; Semel D; Chew ML; Sporn J Pain; 2014 Oct; 155(10):1943-54. PubMed ID: 24907403 [TBL] [Abstract][Full Text] [Related]
16. Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain. Hewitt DJ; Ho TW; Galer B; Backonja M; Markovitz P; Gammaitoni A; Michelson D; Bolognese J; Alon A; Rosenberg E; Herman G; Wang H Pain; 2011 Mar; 152(3):514-521. PubMed ID: 21185118 [TBL] [Abstract][Full Text] [Related]
18. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M; Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123 [TBL] [Abstract][Full Text] [Related]
19. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074 [TBL] [Abstract][Full Text] [Related]
20. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Siddall PJ; Cousins MJ; Otte A; Griesing T; Chambers R; Murphy TK Neurology; 2006 Nov; 67(10):1792-800. PubMed ID: 17130411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]